{
    "title": "Bluebird bio's gene therapy for blood disorder gets FDA panel backing",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10905383/Bluebird-bios-gene-therapy-blood-disorder-gets-FDA-panel-backing.html",
    "date": "2022-06-10",
    "keywords": [
        "gene",
        "therapy",
        "blood",
        "roy",
        "treatment",
        "friday",
        "approval",
        "disease",
        "panel",
        "betathalassemia",
        "fda",
        "patient",
        "june",
        "disorder",
        "food",
        "drug",
        "administration",
        "vote",
        "confidence",
        "company",
        "beset",
        "decision",
        "committee",
        "surprise",
        "move",
        "elicel",
        "cancer",
        "beticel",
        "agency",
        "year",
        "expectation",
        "product",
        "quarter",
        "officer",
        "member",
        "jeannette",
        "yen",
        "lee",
        "therapys",
        "efficacy",
        "opportunity",
        "life",
        "family",
        "participate",
        "sarah",
        "parent",
        "hope",
        "backtoback",
        "boost",
        "bluebird",
        "march",
        "concern",
        "priority",
        "review",
        "funding",
        "ceo",
        "obenshain",
        "reporting",
        "bengaluru",
        "editing",
        "maju",
        "samuel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}